Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600120253) titled 'The correlation study between chemokine CCL19 and its receptor CCR7 and primary Sjogren's syndrome complicated with anxiety and depression' on March 11.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Guang'an People's Hospital
Condition:
Primary Sjogren's syndrome
Intervention:
Primary Sjogren's syndrome without anxiety or depression group:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2025-09-29
Target Sample Size: Primary Sjogren's syndrome without anxiety or depression group:40;Primary Sjogren's syndrome with anxiety and depression group...